Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA015142-14S1
Application #
3164105
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1978-12-01
Project End
1988-01-31
Budget Start
1986-12-01
Budget End
1988-01-31
Support Year
14
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Crane, Courtney A; Austgen, Kathryn; Haberthur, Kristen et al. (2014) Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. Proc Natl Acad Sci U S A 111:12823-8
Ewens, Andrew; Luo, Liqun; Berleth, Erica et al. (2006) Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Res 66:5419-26
Ewens, Andrew; Mihich, Enrico; Ehrke, M Jane (2005) Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. Anticancer Res 25:3905-15
Ujhazy, Peter; Zaleskis, Gintaras; Mihich, Enrico et al. (2003) Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. Cancer Immunol Immunother 52:463-72
Ehrke, M Jane (2003) Immunomodulation in cancer therapeutics. Int Immunopharmacol 3:1105-19
Berleth, E S; Masso-Welch, P A; Kazim, L A et al. (2001) Expression, tissue distribution, and cellular localization of the antiapoptotic TIP-B1 protein. J Leukoc Biol 69:995-1005
Mihich, E; Ehrke, M J (2000) Anticancer drugs plus cytokines: immunodulation based therapies of mouse tumors. Int J Immunopharmacol 22:1077-81
Mihich, E (2000) Historical overview of biologic response modifiers. Cancer Invest 18:456-66
Ehrke, M J; Verstovsek, S; Maccubbin, D L et al. (2000) Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice. Int J Cancer 87:101-9
Berleth, E S; Ujhazy, P; Meer, J M et al. (1999) Measurement of low-abundance cytokine mRNA in cells of murine lymphoid organs: a new quantitative reverse transcription/polymerase chain reaction method. Cancer Immunol Immunother 48:471-81

Showing the most recent 10 out of 37 publications